|
|
|
|
ETEX Corporation Announces New Video Journal of Orthopaedics Release Featuring ETEX Technology
CAMBRIDGE, Mass., Feb.9 /PRNewswire/ ETEX Corporation, an advanced biomaterials company, announced today the release of a new Video Journal of Orthopaedics feature highlighting ETEX 's proprietary nanocrystalline calcium phosphate technology. (Logo: http:/...
|
|
|
3SBio Gains China Rights to Another Dialysis Drug
3SBio Inc.(NSDQ: SSRX) in-licensed the China rights to a phosphate binder, Nephoxil, from Panacor Bioscience Ltd. of Taiwan. Phosphate binders are routinely prescribed for end stage renal disease, the same population served by 3SBios major products...
|
|
|
Bunge to sell Brazil fertilizer business for $3.8B
Agribusiness company Bunge Ltd.said Wednesday it is selling its fertilizer nutrient assets in Brazil to mining giant Vale SA for $3.8 billion. Vale, based in Brazil, is buying Bunge's 42.3 percent interest in Fertilizantes Fosfatados SA, Brazil's biggest...
|
|
|
New Semiconductor Inspection Tool from Camtek
Camtek Ltd.(NASDAQ and TASE: CAMT) ("Camtek" or the "Company"), today announced the introduction of a new Semiconductor Inspection tool focused on the special requirements of the LED Market. Camtek's Condor 5LED is a new AOI (Automated Optical Inspection)...
|
|
|
Biotechnological: Atkins students work with WFU to make biology more appealing to classmates
High-school students wanting a strong role model would do well to look to DNA Girl.As her official bio says, 'she gives all the instructions and everyone follows.' DNA Girl -- who grew up in Phosphate, Atoms, and went on to Hydrogen Bonds Arts High...
|
|
|
Biotechnological: Atkins students work with WFU to make biology more appealing to classmates
(Winston-Salem Journal - McClatchy-Tribune Information Services via COMTEX) -- High-school students wanting a strong role model would do well to look to DNA Girl.As her official bio says, 'she gives all the instructions and everyone follows.' DNA Girl -- who...
|
|
|
Biotechnological: Atkins students work with WFU to make biology more appealing to classmates
High-school students wanting a strong role model would do well to look to DNA Girl.As her official bio says, "she gives all the instructions and everyone follows." DNA Girl -- who grew up in Phosphate, Atoms, and went on to Hydrogen Bonds Arts High...
|
|
|
Comparison of Treatment of Cherry Angiomata With Pulsed-Dye Laser, Potassium Titanyl Phosphate Laser, and Electrodesiccation
Collyer J et al.Comparison of Treatment of Cherry Angiomata With Pulsed-Dye Laser, Potassium Titanyl Phosphate Laser, and Electrodesiccation.
|
|
|
Does Oral Sodium Phosphate Laxative Induce Hyperphosphatemia?
Oral sodium phosphate (OSP) solution is the osmotic laxative most commonly used for colon cleansing, which in turn is used widely for colonoscopic exploration and colonic and gynecological surgery It is known that OSP can induce severe hyperphosphatemia and...
|
|
|
Oral Sodium Phosphate Laxative Inducing Hyperphosphatemia Relates With Weight
Colon cleansing is used widely for colonoscopic exploration and colonic and gynecological surgery.Oral sodium phosphate (OSP) solution is the osmotic laxative most commonly used for this purpose. It is known that OSP can induce severe hyperphosphatemia and...
|
|
|
Phosphate Elimination in Modalities of Hemodialysis and Peritoneal Dialysis
_ Phosphate Elimination in Modalities of Hemodialysis and Peritoneal Dialysis.
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
BioMarin Pharmaceutical Inc.announced that the European Commission has granted marketing approval for 3,4diaminopyridine, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome. Amifampridine Phosphate Receives Marketing Approval in the EU...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif.'We are excited to bring the first approved therapeutic option to the EU to treat LEMS, a rare, serious and debilitating disease as we expand our commercial portfolio with our fourth approved product,' said Jean-Jacques Bienaime About LEMS...
|
|
|
Lara and Sprott Complete Asset Swap and Private Placement
Lara Exploration Ltd.('Lara' or 'the Company') (TSX VENTURE: LRA) is pleased to report that it has completed the transfer to Sprott Resource Corp. (TSX: SCP) ('Sprott') of its 0.5% royalty on the Mantaro Phosphate Project in Peru in exchange for...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
BioMarin Pharmaceutical Inc.(Nasdaq: BMRN) announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the European...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K, and the factors contained in...
|
|
|
Amifampridine Phosphate Receives Marketing Approval in the EU for LEMS
NOVATO, Calif., Jan.5 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton...
|
|
|
International Drug & Explosives Detection Firm IDenta Corp. Announces New Explosive Detector
The new explosive detector is able to distinguish between Ammonium Nitrate and Ammonium Phosphate Fertilizer.Ammonium Nitrate is an explosive and Ammonium Phosphate Fertilizer is a regular fertilizer (non-explosive). Both substances look the...
|
|
|
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
CAMBRIDGE, Mass., Nov.18, 2009- Genzyme Corporation (Nasdaq: GENZ) today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively...
|
